Guillain–Barré syndrome (GBS) is an acute polyradiculoneuropathy. Symptoms may vary
greatly in presentation and severity. Besides weakness and sensory disturbances, patients …

Guillain–Barré syndrome (GBS) represents a group of acute immune-mediated
polyradiculoneuropathies that is usually characterized by symmetrical limb weakness and …

Background Autoimmune neuropathies can result in long-term disability and incomplete
recovery, despite adequate first-line therapy. Kinesin-5 inhibition was shown to accelerate …

Abstract Background Guillain–Barré syndrome (GBS) often carries a favorable prognosis. Of
adult patients with GBS, 10–30% require mechanical ventilation during the acute phase of …

Guillain–Barré syndrome (GBS) is a rare immune-mediated polyradiculoneuropathy.
Patients typically develop rapidly progressive weakness and sensory deficits that can result …

Objective This article summarizes the clinical features, diagnostic criteria, differential
diagnosis, pathogenesis, and prognosis of Guillain-Barré syndrome (GBS), with insights into …

Objective We have assessed and improved the performance of the modified Erasmus GBS
Outcome Score (mEGOS) among patients with Guillain‐Barré syndrome (GBS) from …

Background and objectives Guillain-Barre syndrome (GBS) is an immune-mediated
neuropathy. This has raised the possibility that the neutrophil-lymphocyte ratio (NLR) may …

ABSTRACT Introduction Guillain–Barré syndrome (GBS) is an immune-mediated poly
(radiculo) neuropathy with a variable clinical outcome. Identifying patients who are at risk of …

Objective This study sought to explore the potential causal relationships among immune cell
traits, Guillain-Barre syndrome (GBS) and metabolites. Methods Employing a two-sample …